The Role of Bovine Kappa-Casein Glycomacropeptide in Modulating the Microbiome and Inflammatory Responses of Irritable Bowel Syndrome
Irritable bowel syndrome (IBS) is a common gastrointestinal disorder marked by chronic abdominal pain, bloating, and irregular bowel habits. Effective treatments are still actively sought. Kappa-casein glycomacropeptide (GMP), a milk-derived peptide, holds promise because it can modulate the gut mic...
Main Authors: | Yunyao Qu, Si Hong Park, David C. Dallas |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/15/18/3991 |
Similar Items
-
Evaluating the Potential of Casein Glycomacropeptide in Adult Irritable Bowel Syndrome Management: A Pilot Study
by: Yunyao Qu, et al.
Published: (2023-09-01) -
Analysis of Bovine Kappa-Casein Glycomacropeptide by Liquid Chromatography–Tandem Mass Spectrometry
by: Yunyao Qu, et al.
Published: (2021-08-01) -
Maternal supplementation with combined galactooligosaccharides and casein glycomacropeptides modulated microbial colonization and intestinal development of neonatal piglets
by: Yujun Wu, et al.
Published: (2020-11-01) -
Glycomacropeptide Safety and Its Effect on Gut Microbiota in Patients with Phenylketonuria: A Pilot Study
by: Chiara Montanari, et al.
Published: (2022-04-01) -
Influence of Glycomacropeptide on Rehydration Characteristics of Micellar Casein Concentrate Powder
by: Ram R. Panthi, et al.
Published: (2021-08-01)